Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease

被引：33

作者：

Cooper, CB ^{[1
]}

Tashkin, DP ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7492期

关键词：

D O I：

10.1136/bmj.330.7492.640

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：640 / 644

页数：7

共 39 条

[1] Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial [J].

Aalbers, R ;

Ayres, J ;

Backer, V ;

Decramer, M ;

Lier, PA ;

Magyar, P ;

Malolepszy, J ;

Ruffin, R ;

Sybrecht, GW .

EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (05) :936-943

[2] The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials [J].

Alsaeedi, A ;

Sin, DD ;

McAlister, FA .

AMERICAN JOURNAL OF MEDICINE, 2002, 113 (01) :59-65

[3] Inhaled corticosteroids and hospitalisation due to exacerbation of COPD [J].

Bourbeau, J ;

Ernst, P ;

Cockcoft, D ;

Suissa, S .

EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :286-289

[4] Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD [J].

Brusasco, V ;

Hodder, R ;

Miravitlles, M ;

Korducki, L ;

Towse, L ;

Kesten, S .

THORAX, 2003, 58 (05) :399-404

[5] Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease [J].

Calverley, PM ;

Boonsawat, W ;

Cseke, Z ;

Zhong, N ;

Peterson, S ;

Olsson, H .

EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :912-919

[6] Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease [J].

Calverley, PMA ;

Lee, A ;

Towse, L ;

van Noord, J ;

Witek, TJ ;

Kelsen, S .

THORAX, 2003, 58 (10) :855-860

[7] Perfluoroalkyl end-capped poly(ethylene oxide).: Synthesis, characterization, and rheological behavior in aqueous solution [J].

Calvet, D ;

Collet, A ;

Viguier, M ;

Berret, JF ;

Séréro, Y .

MACROMOLECULES, 2003, 36 (02) :449-457

[8] The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD [J].

Cazzola, M ;

Di Marco, F ;

Santus, P ;

Boveri, B ;

Verga, M ;

Matera, MG ;

Centanni, S .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2004, 17 (01) :35-39

[9] Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes [J].

Celli, B ;

ZuWallack, R ;

Wang, S ;

Kesten, S .

CHEST, 2003, 124 (05) :1743-1748

[10] Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].

Celli, BR ;

MacNee, W ;

Agusti, A ;

Anzueto, A ;

Berg, B ;

Buist, AS ;

Calverley, PMA ;

Chavannes, N ;

Dillard, T ;

Fahy, B ;

Fein, A ;

Heffner, J ;

Lareau, S ;

Meek, P ;

Martinez, F ;

McNicholas, W ;

Muris, J ;

Austegard, E ;

Pauwels, R ;

Rennard, S ;

Rossi, A ;

Siafakas, N ;

Tiep, B ;

Vestbo, J ;

Wouters, E ;

ZuWallack, R .

EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946

← 1 2 3 4 →